Search results for "COVID-19"
Oral medications for COVID-19 underused among socially vulnerable, CDC study finds
By late May, the rate of prescriptions for molnupiravir and nirmatrelvir/ritonavir was twice as high in the highest-income U.S. ZIP codes as in the lowest, research showed. A CDC webinar on June 28 will discuss efforts to equitably distribute these treatments.
https://immattersacp.org/weekly/archives/2022/06/28/2.htm
28 Jun 2022
New data on COVID-19 vaccines' effectiveness against omicron, among immunocompromised
One English analysis showed how COVID-19 boosters increase protection against symptomatic infection from omicron, while two studies looked at vaccinating the immunocompromised, and ACP videos worked to educate patients and increase vaccine uptake.
https://immattersacp.org/weekly/archives/2022/03/08/2.htm
8 Mar 2022
ACP hosts free webinar, “COVID-19 Recovery: Increasing Adult Vaccinations”
Topics covered will include current recommendations, immunizations in patients with high-risk chronic conditions, and strategies for increasing vaccination rates.
https://immattersacp.org/weekly/archives/2021/07/20/2.htm
20 Jul 2021
ACP, Annals of Internal Medicine host fifth forum on COVID-19
“COVID-19 Forum V: Evaluation and Care of Patients with Persistent Symptoms Following Acute SARS-CoV-2 Infection” was held on June 9.
https://immattersacp.org/weekly/archives/2021/06/15/2.htm
15 Jun 2021
Next ACP, Annals of Internal Medicine COVID-19 forum to focus on persistent symptoms
A virtual live event on June 9 will feature a panel of experts discussing current information on treating patients with persistent symptoms following acute SARS-CoV-2 infection.
https://immattersacp.org/weekly/archives/2021/05/25/2.htm
25 May 2021
Boosters, antithrombotic therapy, mental health effects, more COVID-19 news
FDA advisors recommended booster administration for the Moderna vaccine for certain populations, an ACP/Annals forum covered the immunology of SARS-CoV-2, a trial showed that neither aspirin nor apixaban benefited outpatients with COVID-19, and ACP partnered with YouTube to combat medical misinformation related to COVID-19.
https://immattersacp.org/weekly/archives/2021/10/19/2.htm
19 Oct 2021
Higher risk for DVT, PE, bleeding seen after COVID-19; long-term risk for VTE recurrence may be low
A Swedish study found that patients who had COVID-19 were at higher risk for a first deep venous thrombosis (DVT) for up to three months, pulmonary embolism (PE) for up to six months, and bleeding for up to two months, while a single-center study from France found that risk for venous thromboembolism (VTE) recurrence up to a year after COVID-19 was low.
https://immattersacp.org/weekly/archives/2022/04/12/2.htm
12 Apr 2022
ACP issues policy statement on global COVID-19 vaccine distribution and allocation
The College's statement stresses that physicians have a responsibility to advocate for the health and well-being of patients and communities locally and globally and calls for a coordinated global vaccination effort to be ethical as well as practical.
https://immattersacp.org/weekly/archives/2021/06/22/2.htm
22 Jun 2021
Fourth doses, stealth variant, rapid tests focus of latest COVID-19 research
A fourth vaccine dose increased antibodies but didn't significantly reduce infections in an Israeli study. Antibody response is similar with the stealth variant and with the original omicron variant, a small study showed. Other research found that a rapid antigen test caught most omicron infections, and the vaccines weren't associated with neurological conditions.
https://immattersacp.org/weekly/archives/2022/03/22/4.htm
22 Mar 2022
Breakthrough infections, cardiovascular effects of COVID-19, pandemic mental health
Two new studies reported on infections in fully vaccinated people, while another looked at the rate of myocardial infarction and stroke in patients with COVID-19. A survey found depression and anxiety to be common during the pandemic, and the push for mandatory vaccination of health care workers continued.
https://immattersacp.org/weekly/archives/2021/08/03/4.htm
3 Aug 2021